Weight maintenance on cost‐effective antiobesity medications after 1 year of <scp>GLP‐1</scp> receptor agonist therapy: a real‐world study
Patients successfully treated with GLP-1 RAs can maintain their weight loss using generic older-generation AOMs, suggesting potential cost savings for insurers and implications for policy regarding AOM coverage.
Authors
- Nina U. Paddu
- Sabrina J. Poon (ORCID: https://orcid.org/0000-0002-6616-7650)
- Brianna Lawrence
- Gitanjali Srivastava (ORCID: https://orcid.org/0000-0002-8326-3089)
- Stuart J. Wong (ORCID: https://orcid.org/0000-0002-0447-871X)
Institutions
- Vanderbilt University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Obesity
- Published
- 2024-11-18
- DOI
- https://doi.org/10.1002/oby.24177
- Citations
- 17
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.08